Akira Sugiyama

Akira Sugiyama

Auto-generated profile, based on publicly available information

Akira Sugiyama


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2012 in Protein Science
Verified
Journal Article
Open access
PDF file
KYKyohei Yumura
Kyohei Yumura
MUMihoko Ui
Mihoko Ui
HDHirofumi Doi
Hirofumi Doi
THTakao Hamakubo
Takao Hamakubo
TKTatsuhiko Kodama
Tatsuhiko Kodama
ASAkira Sugiyama
Akira Sugiyama
The defining property of core streptavidin (cSA) is not only its high binding affinity for biotin but also its pronounced thermal and chemical stability. Although potential applications of these properties including therapeutic methods have prompted much biological research, the high immunogenicity of this bacterial protein is a key obstacle to its clinical use. To this end, we have successfully constructed hypoimmunogenic cSA muteins in a previous report. However, the effects of these mutations on the physicochemical properties of muteins were still unclear. These mutations retained the similar electrostatic charges to those of wild‐type (WT) cSA, and functional moieties with similar hydrogen bond pattern. Herein, we performed isothermal titration calorimetry, differential scanning calorimetry, and sodium dodecyl sulfate–polyacrylamide gel electrophoresis to gain insight into the physicochemical properties and functions of these modified versions of cSA. The results indicated that the hypoimmunogenic muteins retained the biotin‐binding function and the tetramer structure of WT cSA. In addition, we discuss the potential mechanisms underlying the success of these mutations in achieving both immune evasion and retention of function; these mechanisms might be incorporated into a new strategy for constructing hypoimmunogenic proteins.

1 June 2015 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
TKTatsuya Kawato
Tatsuya Kawato
EMEiichi Mizohata
Eiichi Mizohata
TMTomohiro Meshizuka
Tomohiro Meshizuka
HDHirofumi Doi
Hirofumi Doi
TKTakeshi Kawamura
Takeshi Kawamura
ASAkira Sugiyama
Akira Sugiyama

18 February 2015 in Chemistry – An Asian Journal
Verified
Journal Article
Closed access
PDF file
TYTomohiro Yamamoto
Tomohiro Yamamoto
KAKiyoshi Aoki
Kiyoshi Aoki
ASAkira Sugiyama
Akira Sugiyama
HDHirofumi Doi
Hirofumi Doi
TKTatsuhiko Kodama
Tatsuhiko Kodama
MKMotomu Kanai
Motomu Kanai

29 April 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
YTYuta Tani
Yuta Tani
MTMorihito Takita
Morihito Takita
YKYurie Kobashi
Yurie Kobashi
MWMasatoshi Wakui
Masatoshi Wakui
TZTianchen Zhao
Tianchen Zhao
MTMasaharu Tsubokura
Masaharu Tsubokura
Booster vaccination reduces the incidence of severe cases and mortality related to COVID-19, with cellular immunity playing an important role. However, little is known about the proportion of the population that has achieved cellular immunity after booster vaccination. Thus, we conducted a Fukushima cohort database and assessed humoral and cellular immunity in 2526 residents and healthcare workers in Fukushima Prefecture in Japan through continuous blood collection every 3 months from September 2021. We identified the proportion of people with induced cellular immunity after booster vaccination using the T-SPOT.COVID test, and analyzed their background characteristics. Among 1089 participants, 64.3% (700/1089) had reactive cellular immunity after booster vaccination. Multivariable analysis revealed the following independent predictors of reactive cellular immunity: age < 40 years (adjusted odds ratio: 1.81; 95% confidence interval: 1.19–2.75; p-value: 0.005) and adverse reactions after vaccination (1.92, 1.19–3.09, 0.007). Notably, despite IgG(S) and neutralizing antibody titers of ≥500 AU/mL, 33.9% (349/1031) and 33.5% (341/1017) of participants, respectively, did not have reactive cellular immunity. In summary, this is the first study to evaluate cellular immunity at the population level after booster vaccination using the T-SPOT.COVID test, albeit with several limitations. Future studies will need to evaluate previously infected subjects and their T-cell subsets.

1 September 1999 in Journal of Medical Entomology
Verified
Journal Article
Closed access
PDF file
YTYoshio Tsuda
Yoshio Tsuda
MTMasahiro Takagi
Masahiro Takagi
TTTakako Toma
Takako Toma
ASAkira Sugiyama
Akira Sugiyama
IMIchiro Miyagi
Ichiro Miyagi
Movement of adult An. minimus Theobald between larval habitats and feeding sites was investigated by mark-release-recapture in March 1993 on Ishigaki Island, Ryukyu Archipelago, Japan. Unfed (998 females) and fed (1,485 females) cohorts from a laboratory colony were marked with different colors of fluorescent dye, and released near Nishihama stream where larvae were abundant. Overall, 42 fed (2.82%) and 13 unfed (1.30%) females were recaptured. Among these, 12 females were recaptured at a cowshed, the nearest blood meal source. Most females in the fed cohort recaptured at the release point had developing or matured ovaries, whereas 55% at the cowshed were parous. The movement of released females from larval habitat to the cowshed for blood feeding indicated a flight distance >1 km.

1 January 2002 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
PDF file
HWHiromi Wada
Hiromi Wada
KHKiyoshi Hashimoto
Kiyoshi Hashimoto
YWYouichiro Wada
Youichiro Wada
MKMika Kobayashi
Mika Kobayashi
AIAkashi Izumi
Akashi Izumi
TKTatsuhiko Kodama
Tatsuhiko Kodama
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies